MedBioSphere
Articles Videos The Web  
    

gemfibrozil

Selected Abstract

gemfibrozil
gemfibrozil (jem- fy -broh-zil) n. a drug used to treat hyperlipidaemia that has not responded to diet, weight reduction, or exercise (see fibrate ). It is administered by mouth. Trade name: Lopid. ...
January 1, 2008; A Dictionary of Nursing

Read the full article with a free-trial membership at HighBeam Research



Related Articles

1. Gemfibrozil reduces cardiac events in CHD patients with low HDL cholesterol but no other lipid risks
2. With statin, fenofibrate safer than gemfibrozil: risk for rhabdomyolysis increased significantly when gemfibrozil was combined with most statins.(Cardiovascular Medicine)
3. Influence of Gemfibrozil on Sulfate Transport in Human Erythrocytes during the Oxygenation-Deoxygenation Cycle
4. Gemfibrozil aids severe metabolic syndrome.(Clinical Rounds)(Brief article)(Clinical report)
5. FDA Is Urged to Permit Wider Use of Cholesterol Drug; Gemfibrozil's Link to Increased Cancer Risk Unclear
6. Gemfibrozil doesn't slow renal decline.(Clinical Capsules)(Brief Article)
7. Gemfibrozil does not slow renal decline.(CLINICAL CAPSULES)(Brief Article)
8. Study finds good news on Lopid. (gemfibrozil product found to reduce coronary heart disease) (RX Mass Market Retail Pharmacy: Marketplace)
9. Teva receives FDA approval. (Teva Pharmaceutical Industries' Gemfibrozil cholesterol-reducing agent approved by Food and Drug Administration)
10. gemfibrozil